Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

Kurma Partners (Kurma Life Sciences Partners)

Created in 2009, Kurma Partners is an European leading venture capital group specialized in Life Sciences and managing Kurma Biofund I, Kurma Biofund II and its accelerator fund, Kurma Diagnostics. The company has more than €250 million under management and develops an investment strategy supported by both the selection of the best investment opportunities in Europe and the development of a "proprietary" portfolio of companies in which Kurma steps in at creation stage. *


Period Start 2009-07-01 established
  Group Kurma (Group)
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Laugel, Thierry (Kurma Life Sciences Partners 201103 Managing Partner at Kurma BioFund before AGF Private Equity)
  Person 2 Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners)
Region Region Paris
  Country France
  Street 5–7 Rue de Monttessuy
  City 75340 Paris Cedex 07
  Tel +33-1-5819-4407
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2020-04-29)
  Currency EUR
  Annual sales 400,000,000 (capital under management (2020) 2020-04-29)
    * Document for �About Section�: DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris.
Record changed: 2021-04-13


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Kurma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC A October 650x80px

» top